Nov 19, 2019
Company makes significant progress in invest-to-grow strategy
Sep 26, 2019
RESEARCH TRIANGLE PARK, NC, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and improve patient outcomes, today announced that it has terminated its previously announced offer to ...
Sep 10, 2019
RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / September 10, 2019 / Adhera Therapeutics, Inc. (OTCQB:ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and improve patient outcomes, announced today that it has entered into a partnership with Indegene Inc. to...
Sep 6, 2019
Co-promote will expand commercialization of NitrolingualĀ® Pumpspray, a Nitroglycerin Lingual Spray
Aug 12, 2019
RESEARCH TRIANGLE PARK, NC, August 12, 2019 -- Adhera Therapeutics, Inc. (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and improve patient outcomes, has partnered with Novos Patient Solutions, LLC, increasing its patient access by 400%. As ...
Jul 2, 2019
RESEARCH TRIANGLE PARK, NC, July 02, 2019 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and improve patient outcomes, today announced that it has terminated its previously announced offer to e...